Type 2 & other diabetes

Complementary value of glycated albumin and continuous glucose monitoring for assessing microvascular complications in type 2 diabetes

Diabetes Res Clin PractPublished Cross-sectional study

Authors' conclusion

In type 2 diabetes, GA is associated with microvascular complications independently of TIR and may provide complementary information when considered alongside TIR.

Study context

Population
Individuals with T2D who underwent continuous glucose monitoring (CGM); Diabetic retinopathy (DR) by fundus examination, diabetic kidney disease (DKD) by urinary albumin excretion and/or eGFR
Participants
3,251 individuals
Exposure
Highest vs lower glycated albumin (GA) tertiles, adjusted including time in range (TIR)
Outcome
DR, DKD and composite microvascular complications (DR and/or DKD), highest GA tertile, adjusted including TIR

Main finding

As reported in the abstract

Estimate (95% CI)
Highest GA tertile
OR (DR) 1.31(1.04–1.64)
Highest GA tertile
OR (DKD) 1.58(1.24–2.02)
Highest GA tertile
OR (composite microvascular complications) 1.44(1.17–1.79)

%

Median GA
20.5 (16.8-25.9)
Median TIR
75.0 (60.0-87.0)
Participants with microvascular complications
45.8

Observational data: associations, not effects.

Further findings

DR, DKD and composite microvascular complications, highest GA tertile, among participants with TIR > 70 %

Estimate
Highest GA tertileOR (DR) 1.38 (CI 1.04–1.83)
Highest GA tertileOR (DKD) 1.95 (CI 1.43–2.65)
Highest GA tertileOR (composite microvascular complications) 1.57 (CI 1.20–2.05)

Discrimination and reclassification for microvascular complications

Improvement in net reclassification adding GA to TIR-based models
13.2-16.3 %
GA and TIR showed comparable C-statistics

Original publication

Complementary value of glycated albumin and continuous glucose monitoring for assessing microvascular complications in type 2 diabetes. Diabetes Res Clin Pract. Published 14 June 2026. doi:10.1016/j.diabres.2026.113372

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.